article thumbnail

Opioid use disorder treatment retention improves with insurance coverage: study

Fierce Healthcare

Insurance network coverage dramatically impacts whether a person remains in treatment for opioid use disorder, according to results shared by treatment provider Ophelia. | In-network insurance coverage goes a long way in making sure individuals continue opioid use disorder treatment, according to a study out of Health Affairs.

article thumbnail

Despite insurance coverage, people living in poor neighborhoods have worse surgical outcomes: study

Fierce Healthcare

Patients living in poor neighborhoods are more likely to have worse postsurgical outcomes even if they’ve got insurance coverage, according to a

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Smoking, Insurance Coverage Show Link in Those With Mental Health Disorders, SUD

Pharmacy Times

The objective of the study was to estimate recent trends in cigarette use and health insurance coverage for US adults with and without mental health and SUD.

article thumbnail

Southern states have low insurance coverage, high costs, new report finds

Fierce Healthcare

Southern states have low insurance coverage, high costs, new report finds. agliadkovskaya. Tue, 10/12/2021 - 16:33.

article thumbnail

Insurance Coverage is Lagging in a Golden Age of Obesity Treatment

Drug Topics

Antiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.

article thumbnail

STAT+: How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed

STAT

Pear received Food and Drug Administration clearance for its app treating substance use disorders and insomnia but insurers mostly refused to cover the novel treatments. For years, the playbook for many companies that wanted to market digital therapeutics was stupid simple: Sell it like a prescription drug.

article thumbnail

Same patient, same drug, same insurer — coverage denied

STAT

Janice Morales-Ferrer is a planner. It’s helped her get ahead in her career and in raising three young kids. But it’s hard to plan when you’ve got a rare disease, especially one with no standard treatment regimen or predictable outcome. “I’m a data-driven person,” said the 46-year-old Boston area resident.